Bioimpedance Spectroscopy-Guided Ultrafiltration Normalizes Hydration and Reduces Intradialytic Adverse Events in...

Area of Science:

• Nephrology
• Biomedical Engineering
• Clinical Medicine

Background:

• Fluid overload and excessive fluid removal significantly increase morbidity and mortality in hemodialysis (HD) patients.
• Current clinical methods for assessing dry weight are often inaccurate, leading to suboptimal fluid management.
• Bioimpedance spectroscopy (BIS) offers a more accurate method for assessing hydration status.

Purpose of the Study:

• To compare the impact of BIS versus traditional clinical methods on guiding ultrafiltration (UF).
• To evaluate the effects on intradialytic complications and blood pressure control in prevalent HD patients.
• To assess changes in hydration status and anti-hypertensive drug burden over a 6-month period.

Main Methods:

• A randomized controlled study involving 50 prevalent HD patients.
• Patients were randomized to either BIS-guided UF or clinically guided UF.
• Body composition monitoring (BCM) was used to assess hydration status, with results revealed only to the managing nephrologist in the BIS group.

Main Results:

• The BIS group showed a significant increase in normal hydration (20% to 88%, p=0.0001), while the clinical group remained similar (40% to 48%, p=0.3).
• Intradialytic hypotension incidence significantly decreased in the BIS group (4.84 events/patient/6 months to 2.8 events/patient/6 months, p=0.003).
• The BIS group experienced a 35% reduction in anti-hypertensive medication burden with comparable blood pressure control.

Conclusions:

• The BIS method accurately determines dry weight, normalizing volume status in HD patients.
• Utilizing BIS for fluid management significantly reduces intradialytic hypotension.
• BIS-guided fluid management leads to a decreased need for anti-hypertensive medications.